Global Label-free Array Systems Market was valued US$ XX Bn. in 2019 and is expected to reach US$ XX Bn. by 2027, at a CAGR of ~7% during a forecast period.
Global Label-free Array Systems Market
(The report study has analysed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.)
Market Dynamics
Label- free detection methods are extensively used to study molecular interactions over conventional label-based detection methods. Label- free detection has received significance in applications where detection using labels can compromise the target characteristic. For instance, fluorescent labels can also compromise protein function. Label-free methods permit actual-time dedication of dissociation and association rates of interacting molecules. Interferometry, surface plasmon resonance (SPR), diffraction, quartz crystal microbalance, and many others are unique techniques which can be used for label-free detection. Surface plasmon resonance (SPR) is the maximum generally used technique for label- free array systems.
The worldwide label-free array systems market growth is driven by using several factors like the developing range of drug discovery projects and growing choice for personalised or precision medicine. Furthermore, prominence with the aid of predominant players on the improvement of novel drug goals for the treatment of diverse chronic diseases, and rising investments in R&D help the growth of the label-free array systems marketplace. The label-free approach gets rid of using heavy fluorescent labels and other labels for the detection of latest molecules. This reduces the price of labelling, and thereby, the overall price of the test.
However, the excessive cost of label- free array systems and alternate label-free technology such as mass spectrometers, microarrays, biochips may additionally obstruct the label-loose array systems market increase throughout the forecast period.
Global Label-free Array Systems Market Segment analysis
Based at the Technology, the surface plasmon resonance segment is projected to grow at a CAGR of XX% during the forecast period. The surface plasmon resonance (SPR) segment held the most important market share in 2019 and will also register quickest growth in the coming years. Surface plasmon resonance can be used as a substitute to dual or single color labeling detection techniques and therefore is an extensively used technique. SPR is a substantially-used technology in drug discovery, kinetic analysis, and antigen-antibody reaction in protein microarray. The big percentage of this technique is credited to easy obtainability and deep penetration.
Based on application, the label- free array systems market is classified into antibody characterization and development, drug discovery, protein complex and cascade analysis, protein interface evaluation and other packages. The drug discovery application segment ruled the market in 2019 because of rising R&D activities and investments for new drug improvement activities. Fast growth is anticipated for antibody characterization and development segment above the estimated period owing to the developing demand for monoclonal antibody.
Global Label-free Array Systems Market Regional analysis
North America is anticipated to dominate the worldwide label-free array systems market throughout the estimate period. North America region accounted for a demand share of XX% in 2019 and is expected to reach as much as XX% by the end of 2027. This large share is credited to rising funds for new target identification and drug discovery by main biotechnology and pharmaceutical businesses and developing demand for modified medicinal drug.
Europe becomes the second important regional market. Growing attention on new therapy development, availability of funds, an emerging number of drug discovery projects, rising demand for monoclonal antibodies are essential factors that help the marketplace increase in this region.
Recent Development
In November 2018, Agilent Technologies, Inc. acquired ACEA Biosciences, Inc. (ACEA), a developer of cell analysis tools, for nearly US$ 250 Mn. in cash, which aided it to expand its label-free array systems portfolio.
The objective of the report is to present a comprehensive analysis of the Global Label-free Array Systems Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding Global Label-free Array Systems Market dynamics, structure by analysing the market segments and projects the Global Label-free Array Systems Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Label-free Array Systems Market make the report investor’s guide.
for more info:https://www.maximizemarketresearch.com/market-report/global-label-free-array-systems-market/60084/
Scope of the Global Label-free Array Systems Market
Global Label-free Array Systems Market, By Technology
• Surface Plasmon Resonance
• Bio Layer Interferometry
• Cellular Dielectric Spectroscopy
• Other Technologies
Global Label-free Array Systems Market, By Application
• Protein Complex and Cascade Analysis
• Antibody Characterization and Development
• Protein Interface Analysis
• Drug Discovery
• Other Applications
Global Label-free Array Systems Market, By End User
• Contract Research Organizations
• Biotechnology and Pharmaceutical Companies
• Academic and Research Institutes
• Other End Users
Global Label-free Array Systems Market, By Regions
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa (MEA)
Key Players operating the Global Label-free Array Systems Market
• GE Healthcare
• Attana AB
• Agilent Technologies, Inc.
• Danaher Corporation
• F. Hoffmann-La Roche AG
• Bio-Rad Laboratories
• GWC Technologies
• PerkinElmer, Inc.
• BiOptix, Inc.
About Us:
Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
0 Comments